Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Cholangiocarcinoma × derazantinib × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 3 Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1 Cholangiocarcinoma 1 Biliary Tract Neoplasms 1 Bile Duct Neoplasms 1

Interventions

zenocutuzumab 1 ulixertinib 1 futibatinib 1 derazantinib 1 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04087876 2025-04-06

Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations

Basilea Pharmaceutica

No longer available

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Liver Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡